Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Silverback Therapeutics
Oncovir, Inc.